Cells . IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients

[tetano]

Cells


. 2020 Dec 12;9(12):E2676.
doi: 10.3390/cells9122676.
IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients


L?onie A N Staats ^{1 2} , Hella Pfeiffer ³ , Jasmin Knopf ^{2 4} , Aylin Lindemann ^{1 2} , Julia F?rst ^{1 2} , Andreas E Kremer ^{1 2} , Holger Hackstein ³ , Markus F Neurath ^{1 2} , Luis E Mu?oz ^{2 4} , Susanne Achenbach ³ , Moritz Leppkes ^{1 2} , Martin Herrmann ^{2 4} , Georg Schett ^{2 4} , Ulrike Steffen ^{2 4}



Affiliations

• PMID: 33322797
• DOI: 10.3390/cells9122676

Abstract

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to an adaptive immune response in the host and the formation of anti-SARS-CoV-2 specific antibodies. While IgG responses against SARS-CoV-2 have been characterized quite well, less is known about IgA. IgA2 activates immune cells and induces inflammation and neutrophil extracellular trap (NET) formation which may contribute to organ injury and fatal outcome in SARS-CoV-2-infected patients. SARS-CoV-2 spike protein specific antibody levels were measured in plasma samples of 15 noninfected controls and 82 SARS-CoV-2-infected patients with no or mild symptoms, moderate symptoms (hospitalization) or severe disease (intensive care unit, ICU). Antibody levels were compared to levels of C-reactive protein (CRP) and circulating extracellular DNA (ecDNA) as markers for general inflammation and NET formation, respectively. While levels of SARS-CoV-2-specific IgG were similar in all patient groups, IgA2 antibodies were restricted to severe disease and showed the strongest discrimination between nonfatal and fatal outcome in patients with severe SARS-CoV-2 infection. While anti-SARS-CoV-2 IgG and IgA2 levels correlated with CRP levels in severely diseased patients, only anti-SARS-CoV-2 IgA2 correlated with ecDNA. These data suggest that the formation of anti-SARS-CoV-2 IgA2 during SARS-CoV-2 infection is a marker for more severe disease related to NET formation and poor outcome.

Keywords: COVID-19; IgA; SARS-CoV-2; inflammation; neutrophil extracellular trap (NET).